Dashboard
Manage Tickers

APLM


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

apollomics-presents-vebreltinib-data-in-patients-with-non-small-cell-lung-cancer-with-metex14-skipping-mutations-at-esmo-congress-2024
Apollomics Presents Vebreltinib Data In Pa...
09/16/2024 12:10:39

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company ...

apollomics-h1-eps-038-up-from-255-yoy-cash-balance-of-259m-to-provide-runway-into-q3-of-2025
Apollomics H1 EPS $(0.38) Up From $(2.55) ...
08/14/2024 10:08:02

sp-500-gains-1-home-depot-earnings-top-views
S&P 500 Gains 1%; Home Depot Earnings Top ...
08/13/2024 16:15:58

why-is-penny-stock-apollomics-trading-higher-on-tuesday
Why Is Penny Stock Apollomics Trading High...
08/13/2024 15:18:39

Apollomics shares soared after revealing promising Phase 2 SPARTA trial data for vebreltinib in non-CNS MET fusion solid tumors...

nasdaq-surges-200-points-us-producer-prices-increase-01-in-july
Nasdaq Surges 200 Points; US Producer Pric...
08/13/2024 13:54:30

apollomics-announces-preliminary-data-of-vebreltinib-in-patients-with-non-cns-met-fusion-solid-tumors-from-phase-2-sparta-trial-showing-43-objective-response-rate
Apollomics Announces Preliminary Data Of V...
08/13/2024 12:06:21

why-chuys-holdings-shares-are-trading-higher-by-47-here-are-20-stocks-moving-premarket
Why Chuy's Holdings Shares Are Trading Hig...
07/18/2024 10:00:28

whats-going-on-with-apollomics-aplm-stock-exploding-higher
What's Going On With Apollomics (APLM) Sto...
07/17/2024 19:20:25

apollomics-granted-180-day-extension-to-regain-compliance-with-nasdaq-minimum-bid-price-requirement
Apollomics Granted 180-Day Extension To Re...
07/16/2024 20:50:21

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company ...

apollomics-reports-vebreltinib-data-at-the-2024-asco-annual-meeting
Apollomics Reports Vebreltinib Data At The...
06/04/2024 12:23:32

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company ...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
05/29/2024 16:31:13

apollomics-announces-6m-private-placement-financing-pursuant-to-the-terms-of-the-subscription-agreements-co-is-selling-an-aggregate-of-19166666-class-a-ordinary-shares-at-a-price-of-030share
Apollomics Announces ~$6M Private Placemen...
05/08/2024 21:28:46

Apollomics Inc. (NASDAQ:APLM), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to addre...

hc-wainwright--co-maintains-buy-on-apollomics-lowers-price-target-to-2
HC Wainwright & Co. Maintains Buy on Apoll...
05/08/2024 19:12:44

HC Wainwright & Co. analyst Robert Burns maintains Apollomics (NASDAQ:APLM) with a Buy and lowers the price target from ...

Core News & Articles
Apollomics Announces Approval Of Vebreltin...
04/25/2024 12:42:24

Apollomics' partner in China, Avistone, received approval from National Medical Products Administration of China to expand ...

apollomics-inc-files-for-mixed-shelf-of-up-to-200m
Apollomics Inc Files For Mixed Shelf Of Up...
04/01/2024 20:34:52

- SEC Filing

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/01/2024 20:31:02

ef-hutton-maintains-buy-on-apollomics-lowers-price-target-to-65
EF Hutton Maintains Buy on Apollomics, Low...
04/01/2024 12:38:58

EF Hutton analyst Michael King maintains Apollomics (NASDAQ:APLM) with a Buy and lowers the price target from $11 to $6.5.

hc-wainwright--co-maintains-buy-on-apollomics-lowers-price-target-to-5
HC Wainwright & Co. Maintains Buy on Apoll...
04/01/2024 10:18:24

HC Wainwright & Co. analyst Robert Burns maintains Apollomics (NASDAQ:APLM) with a Buy and lowers the price target from ...

apollomics-completed-patient-enrollment-for-the-uproleselan-apl-106-phase-3-bridging-study-in-china--topline-data-expected-in-the-first-half-of-2025
Apollomics Completed Patient Enrollment Fo...
03/28/2024 11:07:10

apollomics-fy-eps-232-up-from-844-yoy
Apollomics FY EPS $(2.32) Up From $(8.44) YoY
03/28/2024 11:06:38

Apollomics (NASDAQ:APLM) reported quarterly losses of $(2.32) per share. This is a 72.51 percent increase over losses of $(8.44...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION